| 000 | 01695 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514064538.0 | ||
| 264 | 0 | _c20040121 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(02)00774-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAase, A | |
| 245 | 0 | 0 |
_aComparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease. _h[electronic resource] |
| 260 |
_bVaccine _cMay 2003 |
||
| 300 |
_a2042-51 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Schedule |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aMeningitis, Meningococcal _ximmunology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
| 650 | 0 | 4 | _aPhagocytosis |
| 650 | 0 | 4 | _aRespiratory Burst |
| 650 | 0 | 4 | _aSerum Bactericidal Test |
| 700 | 1 | _aNaess, L M | |
| 700 | 1 | _aSandin, R H | |
| 700 | 1 | _aHerstad, T K | |
| 700 | 1 | _aOftung, F | |
| 700 | 1 | _aHolst, J | |
| 700 | 1 | _aHaugen, I L | |
| 700 | 1 | _aHøiby, E A | |
| 700 | 1 | _aMichaelsen, T E | |
| 773 | 0 |
_tVaccine _gvol. 21 _gno. 17-18 _gp. 2042-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(02)00774-0 _zAvailable from publisher's website |
| 999 |
_c12498108 _d12498108 |
||